Medicinálny Kyslík Kvapalný Sol (Oxygen)

Oxygen delivered by Medicinálny Kyslík Kvapalný Sol diffuses across the alveolar membrane into the bloodstream, raising the partial pressure of oxygen. This increases hemoglobin saturation, allowing more oxygen to be carried to cells where it participates in aerobic metabolism and ATP production, supporting organ function.

The dose of Medicinálny Kyslík Kvapalný Sol is individualized by the prescribing clinician based on the patient’s oxygen saturation, underlying condition, and clinical setting. The prescriber determines flow rate, concentration, and duration according to established medical guidelines.

Oxygen therapy is generally considered safe during pregnancy and breastfeeding when medically indicated, as it does not cross the placenta in harmful amounts. However, the decision to use supplemental oxygen should be made by a qualified healthcare professional who weighs maternal and fetal benefits and risks.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Medicinálny Kyslík Kvapalný Sol offers a high‑purity, liquid‑phase source that can be vaporised on‑site, providing consistent flow rates and ease of storage compared with compressed gas cylinders. It is especially useful where large volumes are needed, but it requires appropriate vapourisation equipment and handling precautions.

Store the liquid oxygen containers at ambient temperature in a well‑ventilated area, away from heat sources, direct sunlight, and open flames. Keep cylinders upright, secure them to prevent tipping, and use only approved vapourisers and delivery systems. Follow all local regulations for medical gases.

The product is vapourised using a certified medical‑grade vapouriser, then delivered to the patient via nasal cannula, face mask, or mechanical ventilation circuit. Administration parameters such as flow rate and FiO2 are set by the healthcare professional based on the patient’s oxygenation goals.

Serious risks include fire or explosion due to oxygen‑rich environments, pulmonary oxygen toxicity from prolonged high concentrations, and central nervous system toxicity leading to seizures. Clinicians should monitor oxygen exposure duration, maintain proper ventilation, and avoid ignition sources near the delivery system.

Patients with untreated pneumothorax, those at high risk of fire exposure, or individuals for whom high‑concentration oxygen is contraindicated (e.g., certain neonatal conditions) should not receive this product unless a specialist determines it is safe and necessary.